2020 to today · Health, Food & Regulators
COVID-19 Hospital Payment Bonuses, Remdesivir Approval, PREP Act Hospital Immunity, and Pre-2020 Pandemic Plans
Period covered: 2017 to 2026 · 37 sources
Summary
In 2020 Congress paid hospitals 20 percent more for every Medicare patient with a COVID-19 diagnosis and then added a bonus for new treatments, the Food and Drug Administration approved remdesivir seven days after the World Health Organization's own trial found it had little or no effect on death, the government told the public not to take ivermectin in words a federal appeals court later said it had no authority to use, and the March 2020 declaration that gave drugmakers immunity was read by a state supreme court in 2026 to shield a hospital from a patient's death. The plans written before the pandemic had said not to do most of what was done: the government's 2017 guidance said an exposed household in a severe pandemic should stay home for up to three days, and the WHO's 2019 guidance said quarantine of the exposed and contact tracing were not recommended in any circumstances. At a Senate roundtable on September 28, 2026, patients, relatives, nurses, and doctors described what they say was done to patients in hospitals; no hospital or health agency took part, and the senator's office has released no report on it.
The CARES Act, signed March 27, 2020, changed what Medicare pays a hospital for a COVID-19 patient. The Centers for Medicare and Medicaid Services described the provision in its own guidance: it would "increase the weighting factor of the assigned Diagnosis-Related Group (DRG) by 20 percent for an individual diagnosed with COVID-19." For admissions on or after September 1, 2020, the agency added a condition that "claims eligible for the 20 percent increase in the MS-DRG weighting factor will also be required to have a positive COVID-19 laboratory test documented in the patient's medical record." For discharges from November 2, 2020 the agency added a second payment, the New COVID-19 Treatments Add-on Payment, which it said was "designed to mitigate potential financial disincentives for hospitals to provide new COVID-19 treatments," paying up to 65 percent of the amount by which a case's costs exceeded the standard payment. It ran until September 30, 2023.
Remdesivir
One of those new treatments was remdesivir, sold by Gilead as Veklury. The Food and Drug Administration authorized it for emergency use on May 1, 2020, on early results from a National Institutes of Health trial. That trial's final report, published in October 2020, found patients who received the drug recovered in a median of 10 days against 15 for placebo; deaths by day 29 were 11.4 percent with the drug and 15.2 percent without, a difference the trial did not find statistically significant. On October 15, 2020 the World Health Organization announced the results of its Solidarity trial, the largest test of the drug, and said remdesivir and three other drugs "appeared to have little or no effect on 28-day mortality." Seven days later, on October 22, 2020, the FDA gave remdesivir full approval, "the first treatment for COVID-19 to receive FDA approval." In November 2020 the WHO's guideline panel issued a conditional recommendation against using it in hospitalized patients, finding "no important effect on mortality, need for mechanical ventilation, time to clinical improvement, and other patient-important outcomes." The panel added that it was "not proving that remdesivir is ineffective; rather, there is no evidence based on currently available data that it does improve patient-important outcomes." In 2022 the WHO reversed itself, with a conditional recommendation for the drug in patients with non-severe disease at the highest risk of hospitalization and then, in September, in patients with severe disease.
Gilead set the price at $3,120 for a course for patients with private insurance. Its own earnings releases record Veklury sales of $2.8 billion in 2020 and $5.6 billion in 2021.
Ivermectin
On August 21, 2021 the FDA posted on social media: "You are not a horse. You are not a cow. Seriously, y'all. Stop it." Eight days later Anthony Fauci said on CNN: "Don't do it; there's no evidence whatsoever that it works and it could potentially have toxicity." Three doctors sued the agency over the posts. On September 1, 2023 the Fifth Circuit Court of Appeals ruled for them, writing: "FDA is not a physician. It has authority to inform, announce, and apprise, but not to endorse, denounce, or advise." The agency, the court said, "has identified no authority allowing it to recommend consumers 'stop' taking medicine." In March 2024 the FDA settled the case by agreeing to retire the consumer page and delete the posts.
What the court decided was who may tell a patient what to take. It did not decide whether the drug worked, and the trials that did are part of the record. The TOGETHER trial, published in March 2022, found hospitalization or a long emergency-room stay in 14.7 percent of patients given ivermectin and 16.3 percent given placebo, and the National Institutes of Health's treatment guidelines describe its result as "no apparent difference." The ACTIV-6 trial, published in October 2022, concluded that ivermectin "did not significantly improve time to recovery," a median of 12 days against 13. In the British PRINCIPLE trial, people who took ivermectin reported recovering about two days sooner, 14 days against 16, a difference the investigators said fell short of their threshold for a meaningful benefit, and they wrote that ivermectin "should not be prescribed as a treatment for COVID-19 in such populations."
In 2021 a Buffalo lawyer, Ralph Lorigo, went to court on behalf of families of hospitalized patients to force hospitals to administer ivermectin, and won orders in several states. The Daily Beast reported in September 2021 that he had "about 40 open cases across the country" and that "it's difficult to define exactly how many cases he's won and lost, since some of his patients have died while legal battles played out." In the interview, Senator Johnson said Lorigo handled about 200 cases, won about 70 in which three patients died, and lost about 120 in which all the patients died. No court record, study, or published tally states those numbers, and they rest solely on the senator's account.
The liability
The March 2020 declaration that gave vaccine makers immunity, which is on the Pfizer page, is broader than vaccines. It defines a covered countermeasure as "any antiviral, any other drug, any biologic, any diagnostic, any other device, or any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID-19," and it makes covered persons "immune from suit and liability under federal and state law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or use by an individual of a covered countermeasure." On March 4, 2026 the Supreme Court of Indiana applied that to a hospital system and its doctors. Elmer Waggoner caught COVID-19 in January 2022, was intubated and put on a ventilator, developed a bed sore while he lay there that turned into a fatal infection, and died on March 29, 2022. His estate sued the hospital system and the doctors, alleging they had failed to treat the sore. The court held that the ventilator was a covered countermeasure and that the claims arose from its use: "Because the Estate's claims arise from the Providers' provision of a covered countermeasure during the public-health emergency, the Providers are 'covered persons' and immune under the PREP Act from civil liability for both federal and state-law claims."
The plans
The government had written down, before 2020, what it would do in a pandemic. The Centers for Disease Control and Prevention's 2017 Community Mitigation Guidelines said that voluntary home quarantine of exposed household members "might be recommended during severe, very severe, or extreme influenza pandemics," and that when it was, "all members of the household should stay home for up to 3 days (the estimated incubation period for seasonal influenza)." The guidelines put face masks for sick people and "preemptive, coordinated school closures and dismissals" in the same category, measures for a severe pandemic. The World Health Organization published its own guidance on non-pharmaceutical measures on September 19, 2019. A 2025 review in Frontiers in Public Health summarizes its recommendations: isolation of the sick at home, hand washing, and masks for people with symptoms were recommended in all circumstances; masks for people without symptoms were conditionally recommended in severe epidemics or pandemics only, along with school and workplace measures and limits on mass gatherings; and "contact tracing and quarantine of exposed individuals" and "entry and exit screening for infection in travelers" were not recommended in any circumstances, with border closure not recommended outside "extraordinary circumstances during a severe pandemic." The senator's phrase for what followed was that "they took the plans and threw them out the window." The documents are the plans.
The information
On December 10, 2020 a group of news organizations and technology companies calling itself the Trusted News Initiative, organized by the BBC, announced it would focus on "combatting the spread of harmful vaccine disinformation," with partners including the Associated Press, Reuters, the Washington Post, the Financial Times, Facebook, Google and YouTube, Microsoft, and Twitter, under an arrangement in which "TNI partners will alert each other to disinformation which poses an immediate threat to life." On January 10, 2023 Children's Health Defense and other publishers sued the Washington Post, the BBC, the Associated Press, and Reuters under the antitrust laws in federal court in Amarillo, Texas, alleging a group boycott through the initiative. The case was moved to Louisiana, and on September 18, 2023 a judge there sent it to the District of Columbia. On July 11, 2025 the Justice Department filed a statement of interest in the case; its release described the suit as alleging that the four organizations "colluded with one another and with the large digital platforms to suppress competition from independent perspectives that rival mainstream media," and the head of the Antitrust Division, Abigail Slater, said: "When companies abuse their market power to block out and deplatform independent voices and protect legacy media, they harm competition and threaten the free flow of information on which consumers depend." No court has ruled on the merits.
The senator's hearings
Johnson has held these sessions since 2022: a panel called "COVID-19: A Second Opinion" on January 24, 2022, a roundtable on vaccine safety on December 7, 2022, and, as chairman of the Permanent Subcommittee on Investigations, a hearing on May 21, 2025 on how health officials handled reports of myocarditis after vaccination. His office announced on September 16, 2026 a roundtable called "COVID-19 Hospital Protocols: Real Stories from Real People," for September 28, 2026 at 1 p.m. in the Kennedy Caucus Room of the Russell Senate Office Building. The advisory says he "will be joined by patients, families, doctors, and nurses to discuss how hospitals failed to administer proper care and treatment to patients suffering from COVID-19 throughout the pandemic," and that they will "share firsthand accounts of mistreatment and other experiences they witnessed at hospitals across the country." The roundtable took place on September 28 as scheduled. The speaker list posted by Children's Health Defense, which carried the livestream, names 21 people: wives, husbands, and other relatives of patients, one patient, nurses, physicians including Pierre Kory, the Oklahoma state senator and physician Randy Grellner, and the attorney Ralph Lorigo. No hospital, medical association, or federal health agency took part. Asked by Spectrum News why no doctors or hospitals had been invited to defend their policies, Johnson said no one had been denied the chance to submit testimony, that hospitals, doctors, and nurses with a different view had not asked to testify, and that his office would post their testimony if they sent it. The American Hospital Association declined to comment to Spectrum News.
Johnson said his office had received 583 testimonies from 46 states. He said he respected doctors, nurses, and modern medicine, apologized to people who had lost someone to what he called cruel hospital policies, and said requests for cheap generic drugs had been refused in favor of remdesivir and ventilators. The accounts were theirs, as Spectrum News and The Center Square reported them. Gail Seiler of Plano, Texas said that when she was admitted unvaccinated in December 2021 an intensive care doctor told her she was going to die, that she was pressed to accept remdesivir and a ventilator and refused the other drugs she asked for, that she was kept from her priest unless she took remdesivir, and that she recovered after her family took her home. Darla Smith of Pennsylvania, who went to court in 2021 to make a hospital give her husband ivermectin, said he never came home. A former trauma surgeon, James Miller, and a nurse, Donna Lowery, said they were disciplined or fired for advocating ivermectin or other treatments. Relatives in recorded testimony described remdesivir given over their objections and a ventilator placed without consent. Lorigo said he had represented 212 families in 40 states and won 72 court orders requiring hospitals to give ivermectin, that three of those patients died, and that all 140 patients in the cases he lost or could not bring in time died. Those are his own counts of his own cases. They are not a study, and the randomized trials described above, which compared patients given ivermectin with patients given a placebo, found no benefit.
None of the reports describe documents released at the roundtable, and as of September 30, 2026 the senator's press page listed no transcript or report of it.
Primary Sources (37)
Documents, court filings, official reports, and broadcasts cited in this report.
Documented Records (1)
Chronological entries extracted from the primary sources above.
Timeline Events (8)
Dated events from this investigation in the site timeline.
More in Health, Food & Regulators
View all stories in Health, Food & Regulators → · Topic overview →
- 2007 to 2026The August 2026 Tariff Waiver for 660 Million Pounds of Foreign Beef Six Days After JBS Met the PresidentOn August 26, 2026 the President signed a proclamation letting 300,000 metric tons of foreign lean beef trimmings, about 660 million pounds, into the country over three months at the low in-quota tariff instead of the 26.4 percent rate that applies above the quota, on the stated ground that ground beef had become too expensive. The Wall Street Journal reported that six days earlier the co-owner of JBS, Joesley Batista, had met the President in the Oval Office and argued for exactly that; the announcement came the next day, and the White House said the decision "was not done as the result of any one conversation." JBS is the Brazilian company whose owners pleaded guilty in the United States in 2020 to bribery, admitted in Brazil to paying nearly 1,900 politicians, and bought their American packing plants with money from a Brazilian state bank. In 2017 the Agriculture Department had halted fresh Brazilian beef after refusing 11 percent of it at the border against 1 percent for the rest of the world. Since 2015 beef in the store has not had to say what country it came from. The week the quota opened, Europe stopped taking Brazilian beef over antibiotic use, the American cattle herd stood at its smallest since 1951, cattle prices fell, and the retail price of ground beef was $6.92 a pound.Health, Food & Regulators
- 1984 to 2026Anthony Fauci's Record: Private Mask Emails, Wuhan Lab Grants, Preemptive Pardon, and Pleadings of the FifthAnthony Fauci ran the National Institute of Allergy and Infectious Diseases for 38 years, was the highest paid employee of the federal government, and in 2020 became the government's voice on the pandemic. The government's own documents record: the email in which he told a cabinet secretary that masks are not really effective and that he did not recommend one, a month before he said the same on television and four months before he explained the advice had been about preserving supply; the herd immunity number he said he nudged up as the polls moved; the six-foot rule that, in his words to Congress, sort of just appeared; the Senate testimony that NIH had not funded a kind of research in Wuhan, and the NIH letter five months later describing an experiment there that EcoHealth failed to report; the audit, the suspension, and the debarment of the grantee; the pardon covering January 2014 to January 2025; the emails in which he wrote please delete this e-mail after you read it; and the day in July 2026 when, under subpoena, he invoked the Fifth Amendment more than a hundred times, after which a Senate committee voted to hold him in contempt.Health, Food & Regulators
- 2021 to 2026The 2026 Health Insurance Premium Spike After ACA Tax Credits ExpiredThe larger premium credits that had made insurance on the exchanges affordable since 2021 expired on December 31, 2025. Congress shut the government for 43 days over them in the fall, took a Senate vote that failed, passed a three year extension in the House in January by 230 to 196, and let it die. Enrollment fell from 22.1 million to 19.2 million, premium payments rose 58 percent for the people who stayed, deductibles rose $1,000, and the budget office expects more than 4 million more people uninsured by 2034, on top of the 10 million from the July 2025 law.Health, Food & Regulators
- 2018 to 2026Boeing 737 MAX Crashes: How the FAA Let Boeing Certify Its Own Planes and the DOJ Dropped Criminal ChargesTwo new Boeing 737 MAX jets crashed in October 2018 and March 2019, killing 346 people, because of a flight control system the company had not fully disclosed to the regulator, the airlines, or the pilots. A congressional investigation found a horrific culmination of faulty assumptions, a lack of transparency, and grossly insufficient oversight by the FAA, which had delegated much of the plane's certification to Boeing's own employees. The Justice Department charged the company with fraud and let it defer prosecution for $2.5 billion. Boeing broke the agreement, a door blew off another MAX in 2024, and in 2025 the government dropped the charge for $1.1 billion. A federal judge said the deal failed to secure the necessary accountability, and that he could not stop it.Health, Food & Regulators
- 1981 to 2026Alaska's Yukon King Salmon Collapse and Factory Trawler Bycatch in the Bering SeaThe Yukon River's king salmon run averaged nearly 400,000 fish a year from 1981 to 1997 and fell below 40,000 in 2022 and 2023. Fishing for Yukon kings has been closed since 2021, and in 2024 Alaska and Canada agreed to suspend it for seven years. In 2025 the pollock trawl fleet in the Bering Sea caught 19,773 king salmon and 151,334 other salmon as bycatch, and trawlers in the Gulf of Alaska caught 15,698 kings and 15,965 other salmon. NOAA's scientists tie the collapse mainly to a warming ocean, and a 2026 study found that bycatch had little effect on the one Yukon stock it examined. Many Alaskans blame the trawl fleet and the federal council that regulates it, where in 2024 four of the eleven voting members worked in or had financial ties to the trawl industry. The fight has become a central issue in Alaska's 2026 Senate race.Health, Food & Regulators